Literature DB >> 7850410

Dopamine action and metabolism in the kidney.

A Aperia1.   

Abstract

Dopamine is one of the major natriuretic hormone. It acts as an autocrine or paracrine factor to inhibit Na+ transport in several tubular segments. Na+,K(+)-ATPase is an important target protein for dopamine. Studies of the tubular effects of dopamine have provided new information about the coupling of dopamine to intracellular signaling systems and about the molecular mechanism for dopamine interaction with other hormones. Several lines of evidence now suggest that abnormalities of the renal dopamine system can lead to salt-sensitive hypertension.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7850410     DOI: 10.1097/00041552-199401000-00005

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  5 in total

1.  Receptor recruitment: a mechanism for interactions between G protein-coupled receptors.

Authors:  U Holtbäck; H Brismar; G F DiBona; M Fu; P Greengard; A Aperia
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

2.  Nuclear localization of catechol-O-methyltransferase in neoplastic and nonneoplastic mammary epithelial cells.

Authors:  J Weisz; G Fritz-Wolz; S Gestl; G A Clawson; C R Creveling; J G Liehr; D Dabbs
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

3.  Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule.

Authors:  H F Cheng; B N Becker; R C Harris
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

4.  Renalase regulates renal dopamine and phosphate metabolism.

Authors:  Daria Sizova; Heino Velazquez; Benedita Sampaio-Maia; Janete Quelhas-Santos; Manuel Pestana; Gary V Desir
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-17

5.  Effects of allopurinol and vitamin E on renal function in patients with cardiac coronary artery bypass grafts.

Authors:  Nader Nouri-Majalan; Ehsan Fotouhi Ardakani; Khalil Forouzannia; Hosein Moshtaghian
Journal:  Vasc Health Risk Manag       Date:  2009-06-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.